Boston Scientific Corporation
BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardiovā¦ read more
Healthcare
Medical Devices
34 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$48.01
Price+2.73%
$1.28
1Y
Price
Market Cap
$71.352b
Large
Price/Earnings 3y Avg5y Avg
15.5x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+25.5%
EBITDA Margin+16.7%
Net Profit Margin+3.1%
Free Cash Flow Margin+25.5%
EBITDA Margin+16.7%
Net Profit Margin+3.1%
Free Cash Flow MarginRevenue
$20.996b
+4.6%
1y CAGR+14.0%
3y CAGR+13.6%
5y CAGREarnings
$3.667b
+27.1%
1y CAGR+33.0%
3y CAGR+56.8%
5y CAGREPS
$2.46
+26.8%
1y CAGR+32.9%
3y CAGR+59.2%
5y CAGRBook Value
$26.104b
$44.351b
Assets$18.247b
Liabilities$11.029b
DebtDebt to Assets
24.9%
1.9x
Debt to EBITDAFree Cash Flow
$3.442b
-5.9%
1y CAGR+29.2%
3y CAGR+43.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company